Artiva Biotherapeutics (ARTV) EBT (2023 - 2024)
Historic EBT for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q4 2024 value amounting to -$16.1 million.
- Artiva Biotherapeutics' EBT fell 4130.15% to -$16.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$61.9 million, marking a year-over-year change of. This contributed to the annual value of -$65.4 million for FY2024, which is 12819.39% down from last year.
- Artiva Biotherapeutics' EBT amounted to -$16.1 million in Q4 2024, which was down 4130.15% from -$16.5 million recorded in Q3 2024.
- Artiva Biotherapeutics' EBT's 5-year high stood at $11.2 million during Q3 2023, with a 5-year trough of -$16.5 million in Q3 2024.